With unprecedented access to space, we can now leverage microgravity to inform the entire drug discovery, design, and development process. Microgravity research is bringing new scientific insights that could enable innovative therapies and allow pharmaceutical companies to return previously shelved drugs that failed to deliver their full potential to the development pipeline.
Over the past year, Redwire has successfully transformed the drug development landscape with two new groundbreaking achievements for terrestrial pharmaceutical and space-based manufacturing through our PIL-BOX technology currently operating on the International Space Station. These breakthroughs offer researchers opportunities to develop novel drug forms that could offer more potency, fewer side effects, or entirely new properties and the ability to use seed crystal templates for mass production back here on Earth.
Learn more about how pharmaceutical researchers are leveraging microgravity and Redwire’s latest game-changing discoveries in the Mission Report: Crystal Frontier – How Space-Based Manufacturing will Revolutionize Drug Discovery by Redwire’s Chief Scientist Dr. Ken Savin.
